Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess

European Journal of Endocrinology

Volumn 151, Issue 6, 2004, Pages 771-777

  Kim, Jaime ^a   Reutrakul, Sirimon ^a   Davis, Dawn Belt ^a   Kaplan, Edwin L ^a   Refetoff, Samuel ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ADRENALIN; ASPARTATE AMINOTRANSFERASE; CALCIUM; CAPTOPRIL; CATECHOLAMINE; CREATINE KINASE MB; CREATININE; DIGOXIN; DIURETIC AGENT; FUROSEMIDE; GLUCOSE; GLYCERYL TRINITRATE; MILRINONE; NORADRENALIN; PARATHYROID HORMONE; PROTEIN RET; THYROTROPIN; TROPONIN I;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOMYOPATHY; CASE REPORT; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CESAREAN SECTION; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; GENETIC COUNSELING; HEART EJECTION FRACTION; HUMAN; HYPERTENSION; LUNG EDEMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PREGNANCY; PRIORITY JOURNAL; PROTO ONCOGENE; RESPIRATORY FAILURE; SINUS TACHYCARDIA; SIPPLE SYNDROME; ST SEGMENT DEPRESSION; SYMPTOM; THORAX PAIN; THYROID MEDULLARY CARCINOMA;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADRENALECTOMY; ADULT; CARDIOMYOPATHIES; CATECHOLAMINES; FEMALE; HUMANS; LABOR, OBSTETRIC; METANEPHRINE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PEDIGREE; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; PREGNANCY; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 11844283923     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510771     Document Type: Article

References (33)

1. Hicks RJ, Wood B, Kalff V, Anderson ST & Kelly MJ. Normalization of left ventricular ejection fraction following resection of pheochromocytoma in a patient with dilated cardiomyopathy. Clinical Nuclear Medicine 1991 16 413-416.
2. Scott I, Parkes R & Cameron DP. Phaeochromocytoma and cardiomyopathy. The Medical Journal of Australia 1988 148 94-96.
3. Kim HJ, Kim DK, Lee SC, Yang SH, Yang JH & Lee WR. Pheochromocytoma complicated with cardiomyopathy after delivery - a case report and literature review. Korean Journal of Internal Medicine 1998 13 117-122.
4. Hermayer KL & Szpiech M. Diagnosis and management of pheochromocytoma during pregnancy: a case report. The American Journal of the Medical Sciences 1999 318 186-189.
5. Satani O, Katsuragi M, Hano T, Tomobuchi Y, Arita M & Nishio I. Pheochromocytoma-related myocardial damage following delivery. Hypertension Research 1996 19 291-293.
6. Nanda AS, Feldman A & Liang CS. Acute reversal of pheochromocytoma-induced catecholamine cardiomyopathy. Clinical Cardiology 1995 18 421-423.
7. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R & Gibbons DO. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. British Heart Journal 1990 63 234-237.
8. Lam JB, Shub C & Sheps SG. Reversible dilatation of hypertrophied left ventricle in pheochromocytoma: serial two-dimensional echocardiographic observations. American Heart Journal 1985 109 613-615.
9. Shub C, Cueto-Garcia L, Sheps SG, Ilstrup DM & Tajik AJ. Echocardiographic findings in pheochromocytoma. American Journal of Cardiology 1986 57 971-975.
10. Gatzoulis KA, Tolis G, Theopistou A, Gialafos JH & Toutouzas PK. Cardiomyopathy due to a pheochromocytoma. A reversible entity. Acta Cardiologica 1998 53 227-229.
11. Elian D, Harpaz D, Sucher E, Kaplinsky E, Motro M & Vered Z. Reversible catecholamine-induced cardiomyopathy presenting as acute pulmonary edema in a patient with pheochromocytoma. Cardiology 1993 83 118-120.
12. Gomez Ramos MJ, Gonzalez Valverde FM & Sanchez Alvarez MC. Sipple's syndrome presenting acutely as severe heart failure. European Journal of Emergency Medicine 2002 9 171-174.
13. Kothari SN & Kisken WA. Dexamethasone-induced congestive heart failure in a patient with dilated cardiomyopathy caused by occult pheochromocytoma. Surgery 1998 123 102-105.
14. Haas GJ, Tzagournis M & Boudoulas H. Pheochromocytoma: catecholamine-mediated electrocardiographic changes mimicking ischemia. American Heart Journal 1988 116 1363-1365.
15. Suga K, Tsukamoto K, Nishigauchi K, Kume N, Matsunaga N, Hayano T & Iwami T. Iodine-123-MIBG imaging in pheochromocytoma with cardiomyopathy and pulmonary edema. Journal of Nuclear Medicine 1996 37 1361-1364.
16. Harper MA, Murnaghan GA, Kennedy L, Hadden DR & Atkinson AB. Phaeochromocytoma in pregnancy. Five cases and a review of the literature. British Journal of Obstetrics and Gynaecology 1989 96 594-606.
17. Bailit J & Neerhof M. Diagnosis and management of pheochromocytoma in pregnancy: a case report. American Journal of Perinatology 1998 15 259-262.
18. Wood R, Commerford PJ, Rose AG & Tooke A. Reversible catecholamine-induced cardiomyopathy. American Heart Journal 1991 121 610-613.
19. Mishra AK, Agarwal G, Kapoor A, Agarwal A, Bhatia E & Mishra SK. Catecholamine cardiomyopathy in bilateral malignant pheochromocytoma: successful reversal after surgery. International Journal of Cardiology 2000 76 89-90.
20. Mootha VK, Feldman J, Mannting F, Winters GL & Johnson W. Pheochromocytoma-induced cardiomyopathy. Circulation 2000 102 E11-E13.
21. Quezado ZN, Keiser HR & Parker MM. Reversible myocardial depression after massive catecholamine release from a pheochromocytoma. Critical Care Medicine 1992 20 549-551.
22. Salathe M, Weiss P & Ritz R. Rapid reversal of heart failure in a patient with phaeochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril. British Heart Journal 1992 68 527-528.
23. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr & Marx SJ. Guidelines for diagnosis and therapy of MEN type 1 and type 2. Journal of Clinical Endocrinology and Metabolism 2001 86 5658-5671.
24. Modigliani E, Vasen HM, Raue K, Dralle H, Frilling A, Gheri RG, Brandi ML, Limbert E, Niederle B, Forgas L, Rosenberg-Bourgin M, Calmettes C & The Euromen Study Group. Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group. Journal of Internal Medicine 1995 238 363-367.
25. Melvin KE, Tashjian AH Jr & Miller HH. Studies in familial (medullary) thyroid carcinoma. Recent Progress in Hormone Research 1972 28 399-470.
26. Sizemore GW. Multiple endocrine neoplasia. In Principles and Practice of Endocrinology and Metabolism, 3rd edn, pp 1704-1705. Ed. KL Becker. Philadelphia: Lippincott Wllliams & Wilkins, 2001.
27. Pomares FJ, Canas R, Rodriguez JM, Hernandez AM, Parrilla P & Tebar FJ. Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma. Clinical Endocrinology 1998 48 195-200.
28. Werbel SS & Ober KP. Pheochromocytoma. Update on diagnosis, localization, and management. The Medical Clinics of North America 1995 79 131-153.
29. Gagel RF, Tashjian AH Jr, Cummings T, Papathanasopoulos N, Kaplan MM, Delellis RA, Wolfe HJ & Reichlin S. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2A. An 18-year experience. New England Journal of Medicine 1988 318 478-484.
30. Lairmore TC, Ball DW, Baylin SB, & Wells SA Jr. Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Annals of Surgery 1993 217 595-601; discussion 601-603.
31. Dluhy RG. Pheochromocytoma - death of an axiom. New England Journal of Medicine 2002 346 1486-1488.
32. Lips CJ. Clinical management of the multiple endocrine neoplasia. syndromes: results of a computerized opinion poll at the Sixth International Workshop on Multiple Endocrine Neoplasia and von Hippel-Lindau disease. Journal of Internal Medicine 1998 243 589-594.
33. 131I-metaiodobenzylguanidine. Annals of Internal Medicine 1981 94 762-767.